South Korea · Delayed Price · Currency is KRW Aprogen Biologics Statistics
Total Valuation
KRX:003060 has a market cap or net worth of KRW 42.37 billion. The enterprise value is 303.98 billion.
| Market Cap | 42.37B |
| Enterprise Value | 303.98B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KRX:003060 has 23.54 million shares outstanding. The number of shares has increased by 5.06% in one year.
| Current Share Class | 23.54M |
| Shares Outstanding | 23.54M |
| Shares Change (YoY) | +5.06% |
| Shares Change (QoQ) | +6.28% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 0.03% |
| Float | 14.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.49 |
| PB Ratio | 0.16 |
| P/TBV Ratio | 0.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.57, with a Debt / Equity ratio of 0.79.
| Current Ratio | 0.57 |
| Quick Ratio | 0.20 |
| Debt / Equity | 0.79 |
| Debt / EBITDA | n/a |
| Debt / FCF | -5.83 |
| Interest Coverage | -6.62 |
Financial Efficiency
Return on equity (ROE) is -23.95% and return on invested capital (ROIC) is -21.62%.
| Return on Equity (ROE) | -23.95% |
| Return on Assets (ROA) | -10.66% |
| Return on Invested Capital (ROIC) | -21.62% |
| Return on Capital Employed (ROCE) | -28.67% |
| Weighted Average Cost of Capital (WACC) | 5.15% |
| Revenue Per Employee | 227.39M |
| Profits Per Employee | -206.59M |
| Employee Count | 379 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 2.21 |
Taxes
| Income Tax | -1.06B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.89% in the last 52 weeks. The beta is -0.19, so KRX:003060's price volatility has been lower than the market average.
| Beta (5Y) | -0.19 |
| 52-Week Price Change | -80.89% |
| 50-Day Moving Average | 2,032.76 |
| 200-Day Moving Average | 5,260.52 |
| Relative Strength Index (RSI) | 33.24 |
| Average Volume (20 Days) | 244,401 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:003060 had revenue of KRW 86.18 billion and -78.30 billion in losses. Loss per share was -5,853.51.
| Revenue | 86.18B |
| Gross Profit | -23.81B |
| Operating Income | -97.91B |
| Pretax Income | -73.65B |
| Net Income | -78.30B |
| EBITDA | -78.50B |
| EBIT | -97.91B |
| Loss Per Share | -5,853.51 |
Balance Sheet
The company has 22.70 billion in cash and 210.84 billion in debt, with a net cash position of -188.14 billion or -7,992.58 per share.
| Cash & Cash Equivalents | 22.70B |
| Total Debt | 210.84B |
| Net Cash | -188.14B |
| Net Cash Per Share | -7,992.58 |
| Equity (Book Value) | 267.71B |
| Book Value Per Share | 13,879.96 |
| Working Capital | -89.12B |
Cash Flow
In the last 12 months, operating cash flow was -32.32 billion and capital expenditures -3.82 billion, giving a free cash flow of -36.14 billion.
| Operating Cash Flow | -32.32B |
| Capital Expenditures | -3.82B |
| Depreciation & Amortization | 19.41B |
| Net Borrowing | 76.58B |
| Free Cash Flow | -36.14B |
| FCF Per Share | -1,535.17 |
Margins
Gross margin is -27.63%, with operating and profit margins of -113.61% and -90.85%.
| Gross Margin | -27.63% |
| Operating Margin | -113.61% |
| Pretax Margin | -85.46% |
| Profit Margin | -90.85% |
| EBITDA Margin | -91.09% |
| EBIT Margin | -113.61% |
| FCF Margin | n/a |
Dividends & Yields
KRX:003060 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.06% |
| Shareholder Yield | -5.06% |
| Earnings Yield | -184.79% |
| FCF Yield | -85.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 13, 2026. It was a reverse split with a ratio of 0.0666666667.
| Last Split Date | Apr 13, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.0666666667 |
Scores
KRX:003060 has an Altman Z-Score of -1.27 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.27 |
| Piotroski F-Score | 3 |